Acquisition - August 29, 2026
Aqilion has received an indicative offer for the company
The company has received an indicative offer for all shares in the company.
Acquisition - August 18, 2026
LEO Pharma acquires dersimelagon rights from Tanabe
LEO Pharma is acquiring worldwide rights to dersimelagon from Japan’s Tanabe Pharma in a deal worth up to USD 435 million, strengthening the Danish company’s rare dermatology pipeline.
Acquisition - August 3, 2026
AstraZeneca and Bristol Myers Squibb in talks on potential USD 400 billion merger
AstraZeneca and Bristol Myers Squibb have held preliminary discussions about a possible merger that would create one of the world’s largest pharmaceutical groups, with a combined value of nearly USD 400 billion, according to reports citing people familiar with the matter (source: Reuters).
Acquisition - July 20, 2026
Samsung Biologics makes tender offer to acquire PolyPeptide Group
The offer values PolyPeptide's equity at approximately CHF 1.46 billion.
Acquisition - July 7, 2026
Asker Healthcare Group acquires Murray Surgical
Asker Healthcare Group has acquired 100% of the shares in Murray Surgical Limited, a distributor of specialist surgical and medical products to the healthcare sector in Ireland.
Acquisition - June 26, 2026
Flerie and Biosergen have agreed on a merger plan
The Board of Directors of Flerie and the Board of Directors of Biosergen have adopted a plan to join forces through a statutory merger between the companies in accordance with the Swedish Companies Act.
